Introduction
The c-myc proto-oncogene was ®rst identi®ed by its homology to v-myc sequences in the oncogenic avian myelocytomatosis MC29 retrovirus (Lemaitre et al., 1996) . The expression of c-myc is activated when quiescent cells are stimulated to enter the cell cycle (Askew et al., 1991; Evan et al., 1992) and many neoplasias harbor translocated or ampli®ed c-myc genes, resulting in elevated Myc protein levels that are thought to contribute to cell cycle progression and an oncogenic state (Gibson et al., 1995; Lemaitre et al., 1996) . Myc is a member of the helix ± loop ± helix/ leucine zipper transcription factor family and its function in growth regulation may be achieved by heterodimerization with Max protein and the activation of target genes via a CAC(G/A)TG nucleotide motif (Lemaitre et al., 1996) . Curiously, the activation of c-myc genes can also enhance apoptosis in cells that are growth arrested (Askew et al., 1991; Evan et al., 1992; Gibson et al., 1995; Shi et al., 1992) and this enhancement can be attenuated by the cytokines, IGF-1 and PDGF (Harrington et al., 1994; O'Connor et al., 1997) . How Myc can contribute to such disparate events as cell division and cell death remains unclear, nor is it known precisely how cellular responses to Myc might vary during progression from a normal to a tumorigenic state, where apoptosis associated with cmyc overexpression is not generally observed.
Possible eectors of Myc include cyclins and their dependent kinases [cdks; (Draetta, 1994; Norbury and Nurse, 1992; Sherr, 1994) ]. As observed with Myc, elevated cyclin levels can result either in transformation (Motokura et al., 1991; Withers et al., 1991) or in apoptosis (Freeman et al., 1994; Hoang et al., 1994; Lahti et al., 1995; Meikrantz et al., 1994; Meikrantz and Schlegel, 1996; Sherr and Roberts, 1995; Shi et al., 1994) , and dominant negative mutants of cdc2, cdk2 and cdk3 can suppress apoptosis (Meikrantz and Schlegel, 1996) . Direct links between the activation of Myc and cdks have been proposed (Galaktionov et al., 1996; Hoang et al., 1994; Rudolph et al., 1996; Steiner et al., 1995) and build on the concept that the inappropriate overexpression of c-myc may cause aberrant cell cycle events as a prelude to apoptosis in cells predisposed to this condition. If so, the promotion of apoptosis in cells overexpressing c-myc may be a protective mechanism by the host against the oncogenic potential of Myc protein (Evan and Littlewood, 1993; Harrington et al., 1994) , suggesting that cells that secondarily acquire the ability to survive the deleterious consequences of excess Myc (while still bene®ting from its proliferative stimulus) would become fully malignant To explore these complex issues, we have focused our attention on the initial responses of cells to c-myc overexpression in an eort to emulate the early changes that may arise during oncogenic progression. Previous experimental systems that were developed to analyse the consequences of c-myc activation relied upon targeted gene ampli®cation (Gibson et al., 1995) , constitutively expressed c-myc genes (Hoang et al., 1994; Wagner et al., 1993) , the use of c-or v-myc genes regulated by heavy metals (Grignani et al., 1990) or thermal shifts (von Weizsaecker et al., 1986) , or, most commonly, the hormonal activation of constitutivelyexpressed Myc-estrogen receptor (Myc-ER) fusion proteins (Eilers et al., 1989) . These systems suer, however, from potential diculties such as cellular adaptation to Myc overexpression, poor inducibility, high basal expression, non-physiological induction conditions, unwanted hormonal eects or the use of chimeric proteins that could display altered functions within cells.
We chose instead to use a bacterial promoter that has been adapted for use in mammalian cells (Gossen and Bujard, 1992) , and describe here the generation of rodent ®broblast cell lines that conditionally express a native c-Myc protein under the control of tetracycline. The cells were derived under conditions that block premature expression of the introduced gene and thus allow us to examine the immediate consequences of targeted elevations in the abundance of c-Myc. We ®nd that the overexpression of native c-Myc greatly enhances apoptosis when cells are serum starved. In addition, this apoptosis is associated with striking elevations in cdk2 activity as previously described (Rudolph et al., 1996; Steiner et al., 1995) and the transient activation of cdk2 is preceded by increases in cdc25A phosphatase (Galaktionov et al., 1996) and followed by increased p27
Kip1 kinase inhibitor levels (Steiner et al., 1995) . Thus, our results con®rm that perturbations in cell cycle regulatory pathways are prominent in myc-overexpressing cells undergoing apoptosis. However, we also detect similar perturbations of cell cycle regulatory proteins in serum-starved cells entering quiescence in the absence of Myc overexpression. This ®nding is inconsistent with a strictly causal role for the cdk2 pathway in apoptosis, and we speculate instead that additional Mycresponsive events must be critical in the choice between quiescence and apoptosis.
Results

A tetracycline-regulated c-myc gene is highly inducible in rodent ®broblasts
Parental murine NIH3T3 (Helbing et al., 1997) and Rat 1 ®broblasts were ®rst transfected with a regulatory plasmid encoding a constitutively expressed tet-VP16 transcriptional activator protein (Gossen and Bujard, 1992; Resnitzky et al., 1994) and then stably transfected with a response plasmid containing a human c-myc gene driven by the tetracycline responsive promoter (Gossen and Bujard, 1992) . Cells were continuously maintained in tetracycline from the time of transfection with the second plasmid to ensure that the expression of the exogenous c-myc gene was suppressed until tests of its function were begun. The removal of tetracycline from exponentially growing tetmyc cells results in the rapid accumulation of native human c-Myc protein (Figure 1a ). Based upon results from several experiments using dierent tet-myc cell lines, we estimate that the abundance of Myc protein in induced tet-myc cells is elevated by tenfold to greater than 100-fold more than levels seen in exponentially growing control cells. These levels fall within the range of c-Myc levels found in serum-stimulated normal ®broblasts and in tumor cells containing ampli®ed cmyc genes (Gibson et al., 1995; Waters et al., 1991) . As expected, the overexpressed protein localizes to the nuclear fraction (Figure 1b) . The consistent patterns of rapid induction in cells naive to c-myc overexpression coupled with high levels of sustained expression of native human c-Myc protein make these cell lines appropriate models for examining the consequences of this overexpression.
Analysis of c-myc expression during serum starvation
To ensure that c-myc expression remains elevated during serum starvation of the tet-myc cells, we measured the abundance of c-myc mRNA by Northern blot analysis in cells that were deprived of serum growth factors. Plates of subcon¯uent tet-myc cells grown in normal medium supplemented with tetracycline were rinsed extensively with PBS, trypsinized and plated at a density of 2610 4 /cm 2 in medium with tetracycline or medium free of tetracycline in order tò preload' the cells with Myc protein at a time when growth conditions were optimal. After 8 h the plates were rinsed and the medium replaced with 0.1% FCS +/7 tetracycline (t=0 h) and RNA was harvested from attached cells at the indicated times (Figure 2) . Hybridization with c-myc probe revealed that the preloaded cells (+myc, 0 h) contained abundant cmyc mRNA, as expected, whereas control cells cultured in the presence of tetracycline displayed negligible levels of transcript after 30 h of starvation, consistent with a quiescent state (Pandey and Wang, 1995) . The abundance of c-myc mRNA remained high for at least 12 h in the serum-starved cells in the absence of tetracycline. At later times the recovery of RNA diminished due to apoptosis within the cell population, resulting in an apparent reduction in hybridization to the c-myc probe. However, if the c-myc signal is Figure 1 Rapid induction of human Myc expression upon removal of tetracycline. A representative induction series of exogenous human c-Myc protein accumulation is shown using rat tet-myc cells. The cells were grown in the presence of tetracycline, washed in PBS and medium without tetracycline was added (t=0). (a) Western blot of nuclear proteins isolated at various times after tetracycline removal probed with the 9E10 anti-human c-Myc antibody (Evan et al., 1985) in the top panel. The parental cell line, RpTA, (lane`C') was run as a negative control. Equal quantities of protein were loaded as evidenced by the Ponceau Rouge stained actin bands in the lower panel. (b) Western blot of cytoplasmic (cyto) and nuclear (nucl) proteins probed for human c-Myc as in (a) corrected for the changes in RNA recovery and cell survival, we ®nd that its abundance in the tet-myc cells without tetracycline remained greatly elevated even 24 h after serum withdrawal.
Serum starvation in combination with myc overexpression induces apoptosis in tet-myc cells
We used several methods to characterize the patterns of cell death displayed by serum deprived mycoverexpressing cells. When viability was measured by MTT assays of mitochondrial function (Mosmant, 1983) , we found that, in contrast to tet-myc cells in the absence of c-myc induction or parental cells, tetmyc cells preloaded for 8 h with Myc quickly died following serum withdrawal (Figure 3a) . The detailed patterns of cell death varied slightly among the various clones of myc-overexpressing cells, but we consistently observed that viability began to decrease by 12 h after serum withdrawal and continued to decrease from 24 to 48 h. Other assays of viability, including trypan blue dye exclusion, colony forming eciency and Hoechst dye assays, gave similar results (not shown). We observed that the dying cells frequently detached from the substratum. When DNA was harvested from oating cells collected from plates where starved tetmyc cells expressed (+) or did not express (7) human c-myc, we observed that the quantity of DNA was much greater in the Myc-overexpressing cultures (re¯ecting the abundant¯oating dead cells) and that the DNA was fragmented into a characteristic nucleosomal`ladder' (Figure 3b ). When total RNA was harvested from¯oating or attached cells and equal quantities loaded onto a gel, we found that the size distribution of rRNA was normal in the attached cells, even in those overexpressing Myc (Figure 3c ). In contrast, the abundant¯oating Myc-overexpressing cells showed severely fragmented rRNA (Houge et al., 1995) . Together these characteristics allow us to conclude that the overexpression of native Myc protein (Houge et al., 1995) , was also observed in the dying, detached (Fl.) cells when Myc was overexpressed. Total RNA was separated by size on an 1% formaldehyde-agarose gel leads to rapid apoptosis of cells that are deprived of serum growth factors. Previous work using constitutively expressing c-myc and Myc-ER cells showed that, along with driving cells into apoptosis, Myc overexpression resulted in the maintenance of a high percentage of cells in S phase upon serum starvation (Evan et al., 1992) . To establish whether our system also resulted in S phase persistence, tet-myc cells were serum-starved in the presence or absence of Myc overexpression, ®xed at various times and then stained with propidium iodide to assess DNA content by FACS analysis. We observe that overexpression of Myc results in a large fraction of cells maintaining a S phase content of DNA (Figure 4a ), even many hours after being deprived of serum growth factors. In contrast, non-overexpressing cells decrease their S phase fraction as they enter into quiescence ( Figure 4a ). To con®rm that the Myc-overexpressing cells retain a high level of DNA synthesis even when starved of growth factors, tet-myc cells were preloaded, serum starved for 24 h, and radiolabeled with 3 Hthymidine. Myc-overexpressing cells incorporated 3 Hthymidine greater than 20-fold more than tet-myc cells not expressing Myc.
To further characterize the apoptotic cell population, we dually-labeled Myc-overexpressing cells for DNA content using propidium iodide and DNA fragmentation using a TUNEL assay. The TUNEL assay used a terminal transferase reaction that incorporates bromo-deoxyuridine (BrdU) on the 3'-hydroxyl ends of single and double stranded DNA. Since apoptotic cells have many of these sites as a result of targeted DNA cleavage, they incorporate excess BrdU compared to non-apoptotic control cells. Detection of incorporated BrdU with a FITCconjugated anti-BrdU antibody revealed that logarithmically growing cells exhibit typical cell cycle kinetics with minimal BrdU incorporation (0 h; Figure 4b ). Upon 48 h serum starvation, however, two distinct cell subpopulations with a high degree of BrdU labeling (up to 50-fold higher than logarithmically growing cells) can be detected. The ®rst has a subdiploid DNA content typical of apoptotic bodies, whereas the second is mainly comprised of cells with a DNA content corresponding to G 1 /S phase, representing cells harvested early after entry into apoptosis before DNA loss is prominent but fragmentation is still occurring (Figure 4b ). Therefore, serum starvation brings about quiescence in tet-myc cells when mycexpression is repressed and extensive apoptotic death and maintenance of DNA synthesis when myc is overexpressed.
Cyclin-dependent kinase 2 activity during apoptosis in myc-overexpressing cells Since Myc-overexpressing cells maintain DNA synthesis yet also undergo apoptosis during serum starvation, it is highly probable that they would display abnormal indices of cell cycle progression such as altered phosphorylation of Rb (Beijersbergen et al., 1994; Hinds, 1995; Lee et al., 1995; Weinberg, 1995) . Indeed, previous studies have proposed direct links between Myc activation and cdk activity Daksis et al., 1995; Hanson et al., 1994; Hoang et al., 1994 ; Jansen-Duerr et al., 1993; Philipp et al., 1994; Rudolph et al., 1996) . However, the relationships among Myc's eects on cdk activity, DNA synthesis and apoptosis remain unclear (Hueber et al., 1997; Pusch et al., 1997; Rudolph et al., 1996; Steiner et al., 1995) . We therefore determined whether cells expressing a native human c-myc gene and undergoing apoptosis as a result of serum starvation might also show altered patterns of cdk kinase activity. Immunoprecipitates using antibodies against the various cdks were prepared using extracts from cells that were serum starved for various times following induction of c-myc. Tet-myc cells were isolated at various times after serum starvation, ®xed and stained with propidium iodide. FACS analyses were performed and the percentage of cells in S phase was determined from four independent experiments and plotted. The exponential curves of best ®t show that Mycoverexpressing cells maintain a high percentage of cells with a DNA content corresponding to S phase, whereas a dramatic reduction in the S phase fraction is seen in cells not overexpressing Myc as they become quiescent. (b) FACS analyses of tet-myc cells in the presence (+Myc) of Myc overexpression. Cells were harvested at t=0 h or 48 h after serum starvation, ®xed and then subjected to a TUNEL assay as an index of apoptosis (DNA Fragmentation; Y-axis) and counterstained with propidium iodide to determine DNA content (X-axis). After 48 h of serum starvation, Myc overexpressing cells show two distinct subpopulations of apoptotic cells: one with a subdiploid DNA content and the other with a DNA content of G 1 /S phase cells. Labeling with BrdU indicates a high degree of DNA fragmentation in apoptotic cells
Of the cdks that were tested (cdks 1, 2, 4 and 6), only cdk2 activity showed a large (up to 20-fold) transient increase in activity against an Rb substrate (Figure 5a ), reaching a peak by 12 h and diminishing thereafter. We were intrigued by the close temporal correlation between the peak in cdk2 kinase activity in Mycoverexpressing cells (12 h) and the onset of massive apoptosis (Figure 3a) . Western blot analyses of these extracts for cdk2 abundance reveal no consistent pattern of accumulation or loss of cdk2 that might account for its peak activation at 12 h after serum withdrawal (Figure 5b) , and therefore the variable kinase activity must arise from other modulating agents.
Modulation of cdk2 activity
Many regulatory factors that modulate cdk2 activity, including dierential dimerization with cyclins, binding to low molecular weight inhibitors such as p21 WAF1/Cip1 and p27 Kip1 , and reversible posttranslational modification of the cdk2 protein, have been suggested to play a role in the eect of Myc upon the cell (Galaktionov et al., 1996; Hoang et al., 1994; Rudolph et al., 1996; Steiner et al., 1995) . We observed no consistent changes in the abundance of known cdk2 partners, cyclins A, D1 or E, that would correlate with cdk2 activation (data not shown). We next determined whether a transient decrease in the abundance of kinase inhibitors might account for the elevation in cdk2 kinase activity at 12 h. Although we did not detect p21 WAF1/Cip1 in any of the tet-myc lines tested [as also observed in Myc-ER cells; (Steiner et al., 1995) ], we found a striking accumulation of p27
Kip1 kinase inhibitor from 24 to 48 h after serum withdrawal (Figure 5c ). This pro®le corresponds with the period when cdk2 kinase activity decreased rapidly from its peak levels at 12 h ( Figure 5a ) and suggests that this decreased activity may be mediated in part by the accumulation of p27 Kip1 . Previous work using Myc-ER cells suggested that cdc25A is an important mediator of Myc-induced cdk2 activity (Galaktionov et al., 1996; Steiner et al., 1995) and that Myc-induced apoptosis requires cdc25A (Galaktionov et al., 1996) . We therefore examined the levels of cdc25A during serum starvation in mycoverexpressing cells (Figure 5d ). Consistent with previous reports (Galaktionov et al., 1996) , we found that the levels of cdc25A were elevated 5 ± 8-fold in cells overexpressing Myc in normal culture conditions at t=0 h (compare to 0 h in Figure 6d ). Cdc25A levels increase further when Myc-overexpressing cells are deprived of serum factors and subsequently decrease by 48 h to low levels. Surprisingly, we found that serum deprivation alone (in the absence of c-myc induction), which leads to cell quiescence instead of apoptosis, also results in a dramatic transient increase in cdk2 activity (up to ninefold; Figure 6a ). As with the myc-overexpressing cells, the relative abundance of cdk2 remains unchanged during serum starvation (Figure 6b ), p27
Kip1 shows a delayed increase (Figure 6c ) and cdc25A abundance ®rst increases and then decreases ( Figure  6d ). Since the cell cycle kinetics dier greatly between cells that are overexpressing Myc and those that are not during serum starvation, we conclude that the transient increases in serum-starvation-induced cdk2 activity and cdc25A abundance are not due simply to cell cycle synchronization and are instead a response to serum starvation per se. High cdk2 activity when cells are entering serum starvation-induced quiescence has also been observed in the parental Rat 1 (RpTA) ®broblasts and NIH3T3 cells, suggesting that this is a more general phenomenon.
Because the tet-myc cells contain intact copies of the endogenous c-myc gene, it was possible that maintenance of threshold levels of rat c-myc expression contributed to the changes in cdk activity observed in Figure 6 . To address this issue, we performed RT ± PCR under semi-quantitative conditions using a primer pair that ampli®es both human and rat c-myc Figure 5 Cdk2 activity and abundance of cdk2, p27
Kip1 and cdc25A vary during apoptosis in Myc-overexpressing cells. Total cell extracts were prepared at various times after serum starvation in 0.1% FCS from rat tet-myc cells preloaded with Myc. (a) Cdk2-containing complexes were immunoprecipitated from equal quantities of protein using an anti-cdk2 (M2) antibody (Santa Cruz Biotechnology) and their activity assayed using a C-terminal GST-Rb protein (C-Rb). As a control, antibody blocked with peptide was used on 12 h cell extracts [B(12) ]. The exposure of the depicted results was chosen to demonstrate the more intense cdk2 activity at 12 h relative to 0 h. Speci®c cdk2 kinase activity in proliferating cells is easily detected at 0 h in longer exposures (not shown). (b) Western blot of equal amounts of total cell extracts probed with an anti-cdk2 (M2) antibody, (c) an anti-p27
Kip1 (C-19) antibody, or (d) an anti-cdc25A (Type 144; Santa Cruz Biotechnology) antibody Figure 6 Cdk2 activity and abundance of cdk2, p27
Kip1 and cdc25A in serum starved tet-myc cells entering quiescence. Total cell extracts were prepared at various times after serum starvation in 0.1% FCS from rat tet-myc cells cultured in the continuous presence of tetracycline to maintain c-myc repression. (a) Cdk2-complex kinase assay and, (b) ± (d) Western blots of total cell extracts as described in Figure 5 . Comparison of Figures 5 and 6 reveals remarkable similarity in the activity and abundance pro®les, indicating that transient changes in cdk activity coincide with entry into states of either apoptosis or quiescence sequences. Restriction enzyme digestion of the PCR products with TaqI reveals the relative proportions of rat versus human transcripts by cleavage of the human PCR product and resistance to cleavage of the rat PCR product. High levels of rat c-myc expression are detected (with human c-myc expression conspicuously absent) at 0 h in tet-myc cells in the presence of tetracycline (7Myc; Figure 7) , indicative of cells in exponential growth. When tetracycline is removed, human c-myc expression is easily detected and endogenous c-myc expression is slightly depressed (+Myc; Figure 7 ), a consequence of autosuppression by ectopic myc proteins as previously reported (Cleveland et al., 1988) . Serum starvation results in the marked reduction of endogenous rat c-myc expression, but in the absence of tetracycline human c-myc expression is maintained (Figure 7 ). Since the levels of endogenous c-myc during serum starvation in the presence of tetracycline do not correlate with cdk2 activity, p27
Kip1 or cdc25A levels, the eects we observe are not dependent on residual expression from the endogenous c-myc gene.
Taken together, our ®ndings demonstrate that transient perturbations in cell cycle regulatory pathways are prominent in cells that are serum-starved irrespective of whether they are overexpressing Myc and undergoing apoptosis, or producing normal levels of Myc and entering quiescence. Thus, we speculate that additional Myc-responsive events beyond those associated with cdk2-dependent pathways are required for this form of programmed cell death.
Discussion
We describe the generation of stable rodent ®broblast cell lines containing a human c-myc gene under the tight control of a tetracycline-regulated promoter.
These cells are unique in that they remain naive to Myc overexpression until repression by tetracycline is removed. We observe that expression of the introduced myc gene is elevated by tetracycline withdrawal to levels similar to those found in many tumor cells that overexpress Myc (Bentley and Groudine, 1986; Marcu et al., 1992) . The tet-myc system possesses distinct advantages over the commonly-used conditionally active Myc-ER fusion protein expression system (Eilers et al., 1989) , although the recent development of a Myc-ER TM chimeric protein has addressed some drawbacks by eliminating unwanted eects of estradiol and transcriptional eects of the estrogen receptor moiety (Littlewood et al., 1995; Solomon et al., 1995) . However, constitutive expression of the chimeric protein (active or inactive) and its abnormal structure may still confound the elucidation of the primary eects of c-Myc. Since the tet-myc cells have not had the opportunity to adapt to c-myc overexpression and since the Myc protein produced is in its native form, these cells will be useful in examining both short-term responses and longer-term adaptive changes that arise following Myc overexpression.
In this report, we demonstrate that: (a) short-term overexpression of native Myc protein in tet-myc cells causes a rapid induction of apoptosis in cells deprived of serum growth factors, whereas the same cells do not die when deprived of serum in the absence of excess Myc; (b) the onset of both apoptosis and quiescence is correlated with transient elevations in cdk2 activity; (c) the transient increase in cdk2 activity coincides temporally with the onset of apoptosis but not with its continuation, and (d) variations in cdk2 activity are dissociable from cell cycle progression, as we ®nd that cdk2 shows a burst in activity at 12 h after the onset of starvation in cells that are entering quiescence as well as in Myc-overexpressing cells where the S phase fraction is maintained.
It is surprising that asynchronously growing cells should increase their levels of cdk2 activity so dramatically en route to becoming quiescent, when cdk2 is normally expected to play a role in the transition from G 1 to S phase (Tsai et al., 1993) . While our results con®rm those of others in that we observe low cdk2 activity after prolonged cellular quiescence (Mueller et al., 1993; Tsai et al., 1993) , we speculate that the pronounced transient increase in cdk2 activity soon after the withdrawal of serum growth factors may re¯ect a stress-type (Mosser et al., 1997; Rassow et al., 1995) response to the onset of starvation conditions. Alternatively, it is possible that the transition from exponential growth to cellular quiescence is an active process that, in addition to the induction of growth arrest genes (Hass, 1994; Zhan et al., 1994) , includes cdk2-dependent pathways to achieve growth suppression.
Our work and that of others (Meikrantz and Schlegel, 1996) suggest that elevated cdk2 activity may play an important role in the cell's decisionmaking process. However, Myc overexpression does not appear to dictate cell fate (apoptosis versus quiescence) directly via elevation of cdk2 activity. Figure 7 RT ± PCR analyses of endogenous rat and exogenous human c-myc gene expression. cDNA was generated from RNA isolated from tet-myc cells at various times after serum starvation in the presence (7Myc) or absence (+Myc) of tetracycline and used as a template for the ampli®cation of expressed rat and human c-myc using the same primer pair. The product was digested with TaqI to determine the relative proportions of human and rat transcripts. The rat PCR product is not cleaved by TaqI and appears as a 412 bp fragment (Rat; upper panel). The human PCR product contains two TaqI restriction sites generating three fragments of 97, 105 and 210 bp (Human; upper panel). The two smaller fragments are not well separated and appear as a single band. The myc reaction products were loaded according to a GAPDH control ampli®cation reaction (GAPDH; lower panel) of cdk2 activity with roscovitine (Rudolph et al., 1996) . Furthermore, it has been argued that Myc-induced apoptosis can be elicited at a variety of points in the cell cycle (Evan et al., 1992) , thus lending additional support to the possibility that the activation of apoptosis by Myc need not necessarily proceed through the agency of cdk2-dependent pathways. Since cdk2 activity is transiently elevated in cells becoming quiescent as well as in cells induced to apoptose by c-Myc, we suggest instead that Myc acts downstream of cdk2 in modulating the threshold for apoptosis (Figure 8 ). In addition, our data do not support the key role proposed for cdc25A as an essential mediator of Myc-enhanced apoptosis (Galaktionov et al., 1996) , because serum starvation of our tet-myc cells resulted in a substantial induction of cdc25A expression levels even when Myc was not induced (Figure 6d) , a condition where apoptosis was not evident (Figure 3 ).
Previous work with Myc-ER cells demonstrated that Myc-induced apoptosis was not inhibited by microinjection of cdk inhibitors nor by chemical inhibition
The precise mechanisms of Myc action remain elusive. Its proposed role as a transcription factor by modulating the expression of several identi®ed target genes suers from modest speci®city and intensity of induction (Grandori et al., 1996; Packham and Cleveland, 1997; Sakamuro et al., 1995) . Similarly, the possible role of c-Myc in activating DNA origins of replication is highly controversial (Iguchi-Ariga et al., 1987; LuÈ scher and Eisenman, 1990 ). However contentious the debate, an underlying commonality in the proposed mechanisms is the ability of Myc to alter chromatin structure. To extend this argument, we note that Myc-overexpressing cells maintain a constant percentage of cells in S phase (Figure 4a ) while only a transient increase in cdk2 activity is observed ( Figure  5a ). This suggests that cdk2 activity can be dissociated from DNA synthesis and cell cycle progression. Indeed, the eects of Myc on G 1 -cdk activities and control of the initiation of DNA replication were independent of one another in logarithmically growing cells expressing the Myc-ER TM construct (Pusch et al., 1997) . Interestingly, myc-overexpressing cells with S phase DNA content also exhibited substantial DNA fragmentation when serum starved (Figure 4b ). Therefore, it is plausible that chromatin may be more susceptible to DNase cleavage as a result of Myc-mediated eects that could include variable histone acetylation. Recent observations that the Mad/Max heterodimer (an antagonistic complex to Myc transformation and transcriptional activation) modulates histone deacetylation may be relevant to this hypothesis (Heinzel et al., 1997) .
It is most reasonable at this stage to speculate that, while cdk2 may participate in the initiation of events leading to cell division, apoptosis or quiescence, the enhancement of apoptosis by Myc is linked to other Myc-dependent pathways that are even more critical. We have recently shown that a novel tumor suppressor, p33
ING1
, modulates Myc-inducesd apoptosis (Helbing et al., 1997) . It has also been reported that Myc-induced apoptosis requires the involvement of the Fas receptor (Hueber et al., 1997) , although this interpretation has recently been questioned (Yeh et al., 1998) . It is clear that additional elements of the pathway linking Myc to apoptosis and the mechanisms of their modulation by Myc overexpression remain to be elucidated, as are the longer term consequences of Myc overexpression and cellular adaptation during tumorigenic progression.
Materials and methods
Generation of rodent ®broblast cell lines stably transfected with a native human c-myc gene under the transcriptional control of tetracycline
We used the tetracycline-controlled expression system (Gossen and Bujard, 1992) that is based upon a two vector system consisting of regulator and response plasmids. The R12 rat ®broblast cell line that is stably transfected with the tTA regulator plasmid, pUHD15-1 (Gossen and Bujard, 1992) , encoding a tTA fusion protein (comprised of E. coli tet repressor and the eukaryotic viral VP16 transcriptional activator domain) was provided by S Reed (Resnitzky et al., 1994) . Stable NIH3T3 mouse ®broblast cell lines (Helbing et al., 1997) were transfected with the same regulator plasmid (provided by H Bujard) using standard calcium phosphate transfection procedures (Sambrook et al., 1989) and selection in 400 mg/ml G418 (Sigma, St Louis, MO, USA). G418 resistant clones were screened for the ability to induce a tetracycline-regulatedgalactosidase control vector (pUHG16-3; H Bujard) in transient transfections and the clone, NIH3T3 pTA, that gave the lowest background level and highest inducibility was chosen for further experiments.
The R12 (renamed RpTA) and NIH3T3 pTA cells were subsequently transfected with a second response plasmid modi®ed from the original pUHD10-3 plasmid (Gossen and Bujard, 1992) as follows. A 70 bp EcoRI/BglII multiple cloning site (MCS) from pIC-20R (Marsh et al., 1984) was inserted into the EcoRI/BamHI sites to generate seven unique restriction sites in place of the original two (yielding a plasmid designated as pTIC). This plasmid was further modi®ed by inserting a hygromycin resistance SalI/BamHI cassette (a gift of I Laird-Oringa) through blunt end ligation into the PvuII site of pTIC, yielding the hTIC plasmid. The hTIC-myc plasmid was generated by sticky and blunt end ligation, respectively, of the hTIC XbaI and SphI sites to a 4575 bp XbaI/EcoRI gene fragment of the human c-myc gene. This fragment spans nt 3507-8082 (Gazin et al., 1984) and includes the complete c-myc exon 2/3 region and second intron with the preferred ATG start codon in exon 2, plus a portion of intron one. It does not contain the weak alternative translation start site found in exon 1 (Gazin et al., 1984) and only p62 Myc protein can be produced. The hTIC-myc plasmid was linearized at a unique FspI restriction enzyme site before transfection. The transfected cells were selected with 100 mg/ml hygromycin and grown in the constant presence of 2 ± 5 mg/ml tetracycline (Sigma) to keep the human c-myc gene repressed. Out of 20 mouse and 37 rat hygromycin-resistant (tet-myc) clones obtained from 2610 7 cells transfected of each type, 8 and 5 clones respectively, had low basal human c-myc expression in the presence of tetracycline and high inducibility (10 ± 4100-fold) upon tetracycline removal as determined by Northern and Western blot analyses. 
Cell maintenance and induction experiments
The tet-myc cells were grown in high glucose Dulbecco's MEM (GIBCO/BRL, Burlington, ON) supplemented with 10% FCS and 2 ± 5 mg/ml tetracycline (Sigma) to maintain human c-myc gene repression. Because induction of c-myc expression was much slower in serum-starved cells (data not shown) and because cell cycle position was reported not to aect Myc-induced apoptosis (Harrington et al., 1994) , we elected to preload asynchronous cells with maximal levels of Myc before serum starvation and to subsequently serum starve the cells. Subcon¯uent cells were washed ®ve times in PBS, detached from the plate with 0.5% trypsin/0.53 mM EDTA in Hanks balanced salt solution (Tryp/EDTA; GIBCO/BRL), pelleted and resuspended in tetracycline-free medium containing 10% FCS. The cells were counted on a hemocytometer and plated at a density of 2610 4 cells/cm 2 in the presence of 10% FCS and with or without tetracycline. Cell density was carefully controlled because the apoptotic response is adversely aected by density (Gibson et al., 1995) . After incubation for 8 h to maximally induce c-myc expression in the absence of tetracycline, the cells were washed twice in PBS and the medium was replaced with that containing 0.1% FCS with or without tetracycline. The cells were incubated for the times indicated before harvesting.
Protein preparation
Nuclear proteins were isolated at the indicated time points as described (Gibson et al., 1992 (Gibson et al., , 1995 . Attached cells were collected with Tryp/EDTA, washed twice in ice cold PBS, resuspended at 5610 7 cells/ml in lysis buer [20 mM HEPES, pH 6.8, 5 mM KCl, 5 mM MgCl 2 , 0.5% Triton X-100, 0.1% Na deoxycholate, 0.1 mM phenylmethylsulfonyl uoride (PMSF)] and triturated 15 times to break open the cells. The nuclei were pelleted, the cytoplasmic fraction removed and saved, and the pellet was washed with 400 ml low salt lysis buer. The washed nuclei were resuspended in lysis buer containing 250 mM NaCl and incubated on ice for 20 min. The remaining debris was pelleted by centrifugation and the supernatant was saved as the nuclear fraction. Protein concentrations were determined by Bradford assay (Biorad) and the samples were stored at 7708C for later use.
Total protein homogenates were prepared as described for the kinase assays below.
Immunoblot analyses
Protein extracts were separated by size on 10% SDSpolyacrylamide gels (Laemmli, 1970 ) using a Protean Minigel apparatus (Biorad) and transferred to nitrocellulose (Towbin et al., 1979) . Transfer eciency and sample loading were assessed immediately after transfer by immersion of the blot in 0.2% Ponceau Rouge S (Sigma) in 3% trichloroacetic acid for 3 min and subsequent rinsing in distilled H 2 O for 2 min. These blots were blocked in PBS/0.15% Tween 20 (PBS/Tween) with 10% skim milk at 378C for 10 min and then incubated in either PBS/Tween with 1% skim milk containing antibodies at dilutions recommended by the supplier (Santa Cruz Biotechnology) or undiluted mouse hybridoma supernatant containing a mouse monoclonal 9E10 anti-human c-Myc antibody (Evan et al., 1985) . After being washed ®ve times for 6 min each in PBS/Tween, the blots were incubated in PBS/Tween with 1% skim milk containing goat anti-mouse or anti-rabbit secondary antibody conjugated to horseradish peroxidase (Pierce). Antigens were detected with an Enhanced Chemiluminescence detection system (Amersham) according to the manufacturer's instructions using Dupont Re¯ection NEF ®lm (NEN Dupont).
RNA isolation and Northern blot analyses
Cells were plated at 2610 4 /cm 2 on 15 cm Corning tissue culture dishes and treated as described above. At the times indicated, the medium was saved and detached (¯oating) cells were isolated by centrifugation at 48C and washed twice with ice cold PBS. Attached cells were washed twice in ice cold PBS with aspiration and the cells were scraped o the dish in the remaining¯uid. The cells (¯oating or attached) were transferred to a 1.5 ml microfuge tube and loosely pelleted. The supernatant was aspirated and 250 ml ice cold TNE (150 mM NaCl, 10 mM Tris-HCl, pH 7.8, 1 mM EDTA) was added. The cells were gently resuspended, 20 ml 10% NP-40 was added and the tube was inverted four times. Nuclei and cell debris were quickly pelleted and the supernatant was added to a tube containing 250 ml 26 PK buer (350 mM NaCl, 20 mM Tris-HCl, pH 7.8, 20 mM EDTA, 1% SDS) and extracted twice with 500 ml 25 : 24 : 1 phenol : chloroform : isoamyl alcohol and once with chloroform. The supernatant was precipitated overnight with 1 ml 95% ethanol at 7208C. The pelleted RNA was resuspended in diethyl pyrocarbonate-treated H 2 O and 10 ± 20 mg were run on a 1% agarose/ 2 M formaldehyde gel. The electrophoretically-separated RNA was transferred to Zetaprobe GT (Biorad) membrane, UV-crosslinked and hybridized to a 416 bp PstI human c-myc exon 2 gene fragment (Gazin et al., 1984) as described (Helbing et al., 1996) .
Cell viability and apoptosis assays
Cell viability was assessed by MTT assays of mitochondrial activity. Cells were washed ®ve times in PBS, trypsinized, counted and seeded at 2610 4 /cm 2 on 24-well Falcon plates in sextuplicates. The cells were preloaded and serumstarved as described above. At the times indicated, 200 ml of a 5 mg/ml stock of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; Sigma] dissolved in PBS was added to 1 ml of medium and the cells were incubated at 378C for 1 h to allow the mitochondria of live cells to generate the blue formazan reaction product (Mosmant, 1983) . The cells were then washed twice with PBS, 200 ml dimethyl sulfoxide (DMSO) added per well to solubilize the reaction products, supernatants transferred to 96-well plates and A 600 determined using a Beckman Biomek 1000 automated laboratory workstation.
For measures of DNA fragmentation, cells were prepared as above and exposed to 0.1% FCS for varying times, then DNA was isolated from¯oating cells on a per plate basis. Equal volumes of lysate were run on a 2% agarose gel and stained with ethidium bromide. RNA laddering (Houge et al., 1995) was assessed using the RNA isolation procedure described above. Other measures of apoptotic cell behavior, including TUNEL assays (ApoTAG kit; ONCOR and ApoBrdU apoptosis detection kit; PharMingen, San Diego, CA, USA), FACS analyses of propidium iodide stained cells and nuclear DNA staining with Hoechst 33258 dye (Oberhammer et al., 1992) , yielded results complementary to those of the MTT assays (data not shown and Figure 4b ).
Kinase assays
In vitro kinase assays were performed as described (Quelle et al., 1993) with minor modi®cations. A C-terminal fragment of the human retinoblastoma (Rb) protein (aa 773 ± 928) fused to glutathione-S-transferase (GST), encoded by the pGEX-GST-C-Rb plasmid (provided by E Harlow and W Kaelin) was isolated as described (Poon et al., 1993) . Tet-myc cells were trypsinized, pelleted and quick frozen in liquid nitrogen at various times following serum starvation. Thawed pellets were lysed in 100 ml/ 2610 6 cells of ice cold lysis buer (50 mM HEPES, pH 8.0, 150 mM NaCl, 2.5 mM EGTA, 1 mM EDTA, 0.1% Tween 20, 100 mM PMSF, 20 units/ml aprotinin, 10 mM bglycerophosphate, 0.1 mM Na 3 VO 4 , 1 mM NaF, 1 mM dithiothreitol). The cell lysates were incubated on ice for 30 min, vortexed, sonicated three times for 10 s each at 48C and centrifuged at 12 000 r.p.m. in a refrigerated microfuge to remove debris. The protein concentration of each lysate was determined using a Biorad protein assay. One hundred and eighty mg of crude homogenate were adjusted to 1 ml with IP buer (50 mM HEPES, pH 8.0, 150 mM NaCl, 2.5 mM EGTA, 1 mM EDTA, 0.1% Tween 20) and precleared with 20 ml Protein G Sepharose beads (Santa Cruz Biotechnology) for 20 min. After centrifugation, the supernatant was transferred to a tube containing either 1 mg anti-cdk2 (M2) antibody (Santa Cruz) or 1 mg anticdk2 (M2) antibody plus preadsorbed blocking peptide and 20 ml Protein G Sepharose beads. After a 2 h rocking incubation at 48C, the beads were successively washed three times in 1 ml IP buer and once with kinase buer (KB: 50 mM HEPES, pH 8.0, 10 mM MgCl 2 , 1 mM EDTA, 1 mM DTT, 20 mM ATP, 10 mM b-glycerophosphate, 0.1 mM Na 3 VO 4 , 1 mM NaF, 2 mM reduced glutathione). After the last wash the supernatant was aspirated and 25 ml of kinase reaction mix (1 mg GST-C-Rb substrate, 16 KB, 10 mCi 32 P-g-ATP) was added. The reaction mix and beads were incubated at 308C for 30 min with occasional agitation and stopped by the addition of SDS ± PAGE loading buer for gel electrophoresis.
FACS analyses
Tet-myc cells were prepared and serum starved as described above. At the indicated times, the cells were stained with propidium iodide (PI) to assess DNA content (Nicoletti et al., 1991) or subjected to dual labeling for DNA fragmentation and DNA content using an Apo-BrdU apoptosis detection kit (PharMingen, San Diego, CA, USA).
For PI staining, 1 ± 5610 6 cells were harvested and washed in PBS before ®xation in 2 ml ice-cold 70% ethanol. Shortly before analysis, the ethanol was removed from the pelleted cells, the cells washed once in 1 ml PBS and resuspended in 500 ml 0.5 mg/ml RNAse A and 50 mg/ml propidium iodide (Sigma) in PBS. After a 15 min incubation at room temperature in the dark, the PI¯uorescence of the nuclei in each sample was determined using a FACScan¯ow cytometer (Becton Dickinson) and ModFitLT version 2.0 software (Verity Software House, Topsham, ME).
Dual labeling for DNA fragmentation and DNA content was performed according to manufacturer's instructions. Brie¯y, cells were isolated at the indicated times and ®xed in 1% paraformaldehyde and subsequently stored in ice-cold 70% ethanol. Once all samples were collected, the cells were washed and subjected to a terminal transferase reaction which incorporates BrdU on the 3'-hydroxyl ends of single and double stranded DNA. Since apoptotic cells have a substantial number of these sites available as a result of targeted DNA cleavage, these cells incorporate a large amount of BrdU compared to non-apoptotic control cells. The incorporated BrdU was detected by an FITC-conjugated anti-BrdU antibody and the cells were counterstained with PI for DNA content.
H-thymidine incorporation assay
Tet-myc cells were seeded at 2610 4 cells/cm 2 in the presence or absence of tetracycline in quintuplicate wells on 24-well plates. Three wells were used for radioactivity incorporation and two wells for cell number determination per sample. After an 8 h preloading, the cells were serum starved for 24 h in medium containing 0.1% dialysed FCS and the cells were radiolabeled with 7.5 mCi 3 H-thymidine for 50 min. The wells were washed three times with PBS, followed by addition of 500 ml of 206 TE/0.5% SDS to lyse the cells. The lysate was transferred to a 5 ml polypropylene tube and the wells were rinsed with an additional 500 ml 206TE/0.5% SDS that was subsequently pooled with the lysate. After a 24 h incubation at room temperature, 4 volumes of ice-cold 10% trichloroacetic acid (TCA) solution was added and the mixed solution was incubated for 15 min on ice. Each sample was aspirated onto a wetted GF/A glass micro®bre ®lter (Whatman, Maidstone, UK) on a vacuum apparatus, rinsed four times with 5 ml 10% TCA and two times with 95% ethanol. The radioactive ®lter paper was transferred to a scintillation vial to which scintillation¯uid was added (EcoLume, ICN, Montreal, PQ) and the samples were counted on a scintillation counter. Radioactive counts were normalized to c.p.m.s per cell for comparison.
RT-PCR analyses
cDNA was generated from RNA isolated from tet-myc cells at various times after serum starvation in the presence or absence of tetracycline as described previously (Helbing et al., 1996) and used as a template for the ampli®cation of expressed rat and human c-myc. Myc-speci®c primers were generated according to the published rat c-myc sequence as follows: Primer ME2/3-1 [nt 4746-4765 (Hayashi et al., 1987) ]: 5'-TCTTCCCCTACCCGCTCAAC and primer ME2/3-2 [nt 6137 ± 6156]: 5'-ACCCTGCCACTGTC-CAACTT to produce a 412 bp product. These primers span the second intron of the c-myc gene to enable detection of any contaminating genomic DNA in cDNA preparations. Both endogenous rat and exogenous human c-myc transcripts are ampli®ed because the human c-myc gene (Gazin et al., 1984) diers from the rat by only one nucleotide in primer ME2/3-1 and 2 nucleotides in the 5' end of primer ME2/3-2. Polymerase chain reactions were performed as described previously (Helbing et al., 1996) using 30 cycles of 20 s at 948C, 1 min at 588C and 1 min at 728C. The PCR products were digested with TaqI to determine the proportion of rat to human c-myc transcripts. The rat PCR product is not cleaved by this enzyme whereas the human PCR product generates three restriction fragments of 97, 105 and 210 bp in size that are readily distinguished by electrophoretic separation on a 3% ethidium bromide/agarose gel. Ampli®cation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts was used as a control (Wong et al., 1994) .
